280 related articles for article (PubMed ID: 19255022)
1. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.
Lewis D; Winner P; Saper J; Ness S; Polverejan E; Wang S; Kurland CL; Nye J; Yuen E; Eerdekens M; Ford L
Pediatrics; 2009 Mar; 123(3):924-34. PubMed ID: 19255022
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
3. Topiramate for migraine prevention: a randomized controlled trial.
Brandes JL; Saper JR; Diamond M; Couch JR; Lewis DW; Schmitt J; Neto W; Schwabe S; Jacobs D;
JAMA; 2004 Feb; 291(8):965-73. PubMed ID: 14982912
[TBL] [Abstract][Full Text] [Related]
4. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
[TBL] [Abstract][Full Text] [Related]
5. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
6. Topiramate in migraine prevention: a double-blind, placebo-controlled study.
Storey JR; Calder CS; Hart DE; Potter DL
Headache; 2001; 41(10):968-75. PubMed ID: 11903524
[TBL] [Abstract][Full Text] [Related]
7. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
8. Topiramate in migraine prevention: results of a large controlled trial.
Silberstein SD; Neto W; Schmitt J; Jacobs D;
Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
[TBL] [Abstract][Full Text] [Related]
9. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study.
Lewis D; Paradiso E
Headache; 2007; 47(10):1409-17. PubMed ID: 18052950
[TBL] [Abstract][Full Text] [Related]
11. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial.
Lakshmi CV; Singhi P; Malhi P; Ray M
J Child Neurol; 2007 Jul; 22(7):829-35. PubMed ID: 17715274
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
Silberstein SD; Hulihan J; Karim MR; Wu SC; Jordan D; Karvois D; Kamin M
Clin Ther; 2006 Jul; 28(7):1002-11. PubMed ID: 16990078
[TBL] [Abstract][Full Text] [Related]
13. The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials.
Dahlöf C; Loder E; Diamond M; Rupnow M; Papadopoulos G; Mao L
Health Qual Life Outcomes; 2007 Oct; 5():56. PubMed ID: 17916258
[TBL] [Abstract][Full Text] [Related]
14. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
Winner P; Gendolla A; Stayer C; Wang S; Yuen E; Battisti WP; Nye JS
Headache; 2006; 46(10):1503-10. PubMed ID: 17115983
[TBL] [Abstract][Full Text] [Related]
15. Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine.
Powers SW; Coffey CS; Chamberlin LA; Ecklund DJ; Klingner EA; Yankey JW; Korbee LL; Porter LL; Hershey AD;
N Engl J Med; 2017 Jan; 376(2):115-124. PubMed ID: 27788026
[TBL] [Abstract][Full Text] [Related]
16. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
[TBL] [Abstract][Full Text] [Related]
17. Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraine.
Freitag FG; Forde G; Neto W; Wang DZ; Schmitt J; Wu SC; Hulihan J
J Am Osteopath Assoc; 2007 Jul; 107(7):251-8. PubMed ID: 17682112
[TBL] [Abstract][Full Text] [Related]
18. Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials.
Edwards KR; Potter DL; Wu SC; Kamin M; Hulihan J
CNS Spectr; 2003 Jun; 8(6):428-32. PubMed ID: 12858132
[TBL] [Abstract][Full Text] [Related]
19. Antiepileptic drugs in migraine prevention.
Mathew NT
Headache; 2001; 41 Suppl 1():S18-24. PubMed ID: 11903536
[TBL] [Abstract][Full Text] [Related]
20. Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials.
Adelman J; Freitag FG; Lainez M; Shi Y; Ascher S; Mao L; Greenberg S; Hulihan J
Pain Med; 2008 Mar; 9(2):175-85. PubMed ID: 18298700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
